TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF GLOBAL BODY COMPOSITION ANALYZERS MARKET 20
1.4 CURRENCY AND PRICING 21
1.5 LIMITATION 21
1.6 MARKETS COVERED 22
2 GLOBAL BODY COMPOSITION ANALYZERS MARKET SEGMENTATION 24
2.1 MARKETS COVERED 24
2.2 GEOGRAPHICAL SCOPE 25
2.3 YEARS CONSIDERED FOR THE STUDY 26
2.4 CURRENCY AND PRICING 26
2.5 RESEARCH METHODOLOGY 27
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 30
2.7 DBMR MARKET POSITION GRID 31
2.8 DBMR VENDOR SHARE ANALYSIS 32
2.9 MULTIVARIATE MODELING 33
2.10 PRODUCT TIMELINE CURVE 33
2.11 SECONDARY SOURCES 34
2.12 ASSUMPTIONS 34
3 MARKET OVERVIEW 35
3.1 DRIVERS 37
3.1.1 RISING NUMBER OF GERIATRIC POPULATION 37
3.1.2 RISING OBESITY 38
3.1.3 GOVERNMENT INITIATIVES 40
3.1.4 INCREASE IN STRATEGIC DECISIONS BY KEY PLAYERS 41
3.1.5 INCREASING DISEASES DUE TO CHANGING LIFESTYLE 41
3.2 RESTRAINTS 43
3.2.1 REGULATORY FRAMEWORK 43
3.2.2 HIGH COST OF EQUIPMENT 43
3.3 OPPORTUNITIES 45
3.3.1 RISING FITNESS INDUSTRY 45
3.3.2 GROWING NUMBER OF WEIGHT LOSS CLINICS 45
3.4 CHALLENGES 46
3.4.1 REQUIREMENT OF TRAINED STAFF 46
3.4.2 INCONSISTENT RESULTS 46
4 EXECUTIVE SUMMARY 47
5 PREMIUM INSIGHTS 49
6 INDUSTRY INSIGHTS 51
7 GLOBAL BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT TYPE 52
7.1 OVERVIEW 53
7.2 BIO IMPEDANCE ANALYZERS (BIA) 54
7.2.1 SINGLE FREQUENCY BIA 55
7.2.2 MULTI FREQUENCY BIA 55
7.2.3 BIO-IMPEDANCE SPECTROSCOPY 55
7.3 DUAL ENERGY X-RAY ABSORPTIOMETRY (DEXA) 56
7.4 SKINFOLD CALIPER 57
7.5 AIR DISPLACEMENT PLETHYSMOGRAPHY (ADP) 57
7.6 OTHERS 58
8 GLOBAL BODY COMPOSITION ANALYZERS MARKET, BY COMPARTMENT MODEL TYPE 59
8.1 OVERVIEW 60
8.2 TWO-COMPARTMENT MODEL 61
8.3 THREE-COMPARTMENT MODEL 61
8.4 MULTI-COMPARTMENT MODEL 62
9 GLOBAL BODY COMPOSITION ANALYZERS MARKET, BY END USER 63
9.1 OVERVIEW 64
9.2 HEALTH FITNESS CLUB 65
9.3 HOSPITALS & CLINICS 66
9.4 ACADEMY 67
9.5 OTHERS 68
10 GLOBAL BODY COMPOSITION ANALYZERS MARKET, BY GEOGRAPHY 69
10.1 OVERVIEW 70
10.2 NORTH AMERICA 75
10.2.1 U.S. 80
10.2.2 CANADA 82
10.2.3 MEXICO 84
?
10.3 EUROPE 86
10.3.1 U.K. 91
10.3.2 GERMANY 93
10.3.3 SPAIN 95
10.3.4 FRANCE 97
10.3.5 ITALY 99
10.3.6 SWITZERLAND 101
10.3.7 NETHERLANDS 103
10.3.8 BELGIUM 105
10.3.9 TURKEY 107
10.3.10 RUSSIA 109
10.3.11 REST OF EUROPE 111
10.4 ASIA-PACIFIC 112
10.4.1 JAPAN 117
10.4.2 CHINA 119
10.4.3 SOUTH KOREA 121
10.4.4 INDIA 123
10.4.5 AUSTRALIA 125
10.4.6 SINGAPORE 127
10.4.7 THAILAND 129
10.4.8 MALAYSIA 131
10.4.9 INDONESIA 133
10.4.10 PHILIPPINES 135
10.4.11 REST OF ASIA-PACIFIC 137
10.5 SOUTH AMERICA 138
10.5.1 BRAZIL 143
10.5.2 REST OF SOUTH AMERICA 145
10.6 MIDDLE EAST AFRICA 146
10.6.1 SOUTH AFRICA 151
10.6.2 REST OF MIDDLE EAST & AFRICA 153
11 GLOBAL BODY COMPOSITION ANALYZERS MARKET, COMPANY LANDSCAPE 154
11.1 COMPANY SHARE ANALYSIS: GLOBAL 154
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 155
11.3 COMPANY SHARE ANALYSIS: EUROPE 156
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 157
?
12 COMPANY PROFILE 158
12.1 OMRON CORORATION 158
12.1.1 COMPANY SNAPSHOT 158
12.1.2 SWOT ANALYSIS 158
12.1.3 REVENUE ANALYSIS 160
12.1.4 COMPANY SHARE ANALYSIS 160
12.1.5 GEOGRAPHICAL PRESENCE 161
12.1.6 PRODUCT PORTFOLIO 161
12.1.7 RECENT DEVELOPMENTS 162
12.1.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 162
12.2 TANITA 163
12.2.1 COMPANY SNAPSHOT 163
12.2.2 SWOT ANALYSIS 163
12.2.3 COMPANY SHARE ANALYSIS 164
12.2.4 GEOGRAPHICAL PRESENCE 164
12.2.5 MANUFACTURING LOCATIONS 165
12.2.6 PRODUCT PORTFOLIO 165
12.2.7 RECENT DEVELOPMENTS 169
12.2.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 169
12.3 INBODY CO.,LTD 170
12.3.1 COMPANY SNAPSHOT 170
12.3.2 COMPANY SHARE ANALYSIS 170
12.3.3 GEOGRAPHICAL PRESENCE 171
12.3.4 PRODUCT PORTFOLIO 171
12.3.5 RECENT DEVELOPMENTS 172
12.4 GE HEALTHCARE (A SUBSIDIARY COMPANY OF GENERAL ELECTRIC) 173
12.4.1 COMPANY SNAPSHOT 173
12.4.2 SWOT ANALYSIS 173
12.4.3 REVENUE ANALYSIS 175
12.4.4 COMPANY SHARE ANALYSIS 175
12.4.5 GEOGRAPHICAL PRESENCE 176
12.4.6 PRODUCT PORTFOLIO 176
12.4.7 RECENT DEVELOPMENT 177
12.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 177
12.5 BEURER 178
12.5.1 COMPANY SNAPSHOT 178
12.5.2 SWOT ANALYSIS 178
12.5.3 COMPANY SHARE ANALYSIS 179
12.5.4 GEOGRAPHICAL PRESENCE 179
12.5.5 PRODUCT PORTFOLIO 180
12.5.6 RECENT DEVELOPMENT 181
12.5.7 DATA BRIDGE MARKET RESEARCH ANALYSIS 181
12.6 SECA 182
12.6.1 COMPANY SNAPSHOT 182
12.6.2 SWOT ANALYSIS 182
12.6.3 COMPANY SHARE ANALYSIS 183
12.6.4 GEOGRAPHICAL PRESENCE 184
12.6.5 MANUFACTURING LOCATIONS 184
12.6.6 PRODUCT PORTFOLIO 185
12.6.7 RECENT DEVELOPMENTS 185
12.6.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 186
12.7 AKERN SRL 187
12.7.1 COMPANY SNAPSHOT 187
12.7.2 PRODUCT PORTFOLIO 187
12.7.3 RECENT DEVELOPMENT 187
12.8 BODYSTAT 188
12.8.1 COMPANY SNAPSHOT 188
12.8.2 PRODUCT PORTFOLIO 188
12.8.3 RECENT DEVELOPMENT 189
12.9 COSMED SRL 190
12.9.1 COMPANY SNAPSHOT 190
12.9.2 GEOGRAPHICAL PRESENCE 190
12.9.3 PRODUCT PORTFOLIO 191
12.9.4 RECENT DEVELOPMENTS 191
12.10 HOLOGIC INC. 192
12.10.1 COMPANY SNAPSHOT 192
12.10.2 REVENUE ANALYSIS 192
12.10.3 GEOGRAPHICAL PRESENCE 193
12.10.4 PRODUCT PORTFOLIO 193
12.10.5 RECENT DEVELOPMENTS 193
12.11 IMPEDIMED LTD AND IMPEDIMED INC. 194
12.11.1 COMPANY OVERVIEW 194
12.11.2 REVENUE ANALYSIS 194
12.11.3 GEOGRAPHICAL PRESENCE 195
12.11.4 PRODUCT PORTFOLIO 195
12.11.5 RECENT DEVELOPMENTS 196
12.12 LAICA 197
12.12.1 COMPANY SNAPSHOT 197
12.12.2 GEOGRAPHICAL PRESENCE 197
12.12.3 PRODUCT PORTFOLIO 198
12.12.4 RECENT DEVELOPMENT 199
12.13 MALTRON INTERNATIONAL LTD 200
12.13.1 COMPANY SNAPSHOT 200
12.13.2 PRODUCT PORTFOLIO 200
12.13.3 RECENT DEVELOPMENT 200
12.14 RJL SYSTEMS. 201
12.14.1 COMPANY SNAPSHOT 201
12.14.2 GEOGRAPHICAL PRESENCE 201
12.14.3 PRODUCT PORTFOLIO 202
12.14.4 RECENT DEVELOPMENTS 202
12.15 SELVAS HEALTHCARE, INC. (A SUBSIDIARY OF SELVAS AI INC.) 203
12.15.1 COMPANY SNAPSHOT 203
12.15.2 REVENUE ANALYSIS 203
12.15.3 PRODUCT PORTFOLIO 204
12.15.4 RECENT DEVELOPMENTS 204
13 CONCLUSION 205
14 QUESTIONNAIRE 206
15 RELATED REPORTS 209